Resonance Health patent granted
Thursday, 13 October, 2005
Perth based Resonance Health (ASX:RHT) has been granted its first European patent.
The patent protects the core invention underlying the FerriScan test for the non-invasive measurement of liver iron concentration. It is the European equivalent to a US patent granted in 2003 which is also being prosecuted in several other jurisdictions.
The company is also prosecuting a second patent family to expand the company's technology platform.
The intellectual property assets relating to the FerriScan test are fully owned by Resonance Health, following its acquisition of Inner Vision Biometrics in May 2005.
$780m Sydney Biomedical Accelerator gains its founding Executive Director
Professor Victoria Cogger has been appointed as founding Executive Director of the Sydney...
Portable point-of-care test detects four common STIs in under an hour
Australian researchers have developed a portable point-of-care test that detects four common...
AusBiotech and Proto Axiom partner on investor-focused life sciences programs
AusBiotech and Proto Axiom have announced a partnership to strengthen national coordination...
